维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="NASONOV EL"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Interleukin-6 re- ceptor inhibition with tocilizumab reduces disease activity in rheu- matoid arthritis with inadequate response to disease-modifying an- tirheumatic drugs: the tocilizumab in combination with traditional disease-modifying anfirheumatic drug therapy study 显示文摘	Genovese MC McKay JD Nasonov EL	2008	Arthritis Rheum2008，58，10：	1
2	Bone mineral density in patients with rheumatoid arthritis 显示文摘	Gukasian DA Nasonov EL Balabanova RM	2001	Ter Arkh2001，73，：	1
3	Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs:the tocilizumab in combination with traditional disease-modifying antirhe-umatic drug therapy study显示文摘	Genovese M C McKay J D Nasonov EL	2008	Arthritis Rheum2008，58，10：	1
4	Soluble adhesion molecules (P-selectin,ICAM-1 and ICAM-3) in rheumatoid arthritis显示文摘	SAMSONOV MIU TILZ GP	1999	Abstract Ter Arkh1999，71，5：	1
5	lntedeu- kin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modif- ying antirheumatic drugs: The toeilizumab in combination with traditional disease-modifying antirheumatic drug therapy study 显示文摘	GENOVESE MC MCKAY JD NASONOV EL	2008	Arthritis Rheum2008，58，10：	1
6	Sys- temic autoimmune rheumatic diseases in 2013:Problems of laboratory diagnosis显示文摘	Nasonov EL Aleksandrova EN Novikov AA	2014	Ter Arkh2014，86，5：	1
7	Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs:the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study显示文摘	Genovese MC McKay JD Nasonov EL	2008	Arthritis Rheum2008，58，10：	1
8	Hemorheological and clinical efficiency of a new phospholipid hepatoprotective drug Phosphogliv in patients with psoriatic arthritis显示文摘	Nasonov EL Korotaeva TV	2003	Biomed Khim2003，49，5：	1
9	Cardiac rhythm and conduction disorders in polymyositis and dermatomyositis显示文摘	Bazhanov NN Khitrov AN Nasonov EL	1998	Kiln Med (Mosk)1998，76，10：	1
10	Interleukin-6receptor inhibition with tocilizumab reduces disease activity inrheumatoid arthritis with inadequate response to disease-modify-ing antirheumatic drugs: the tocilizumab in combination withtraditional disease-modifying antirheumatic drug therapy study 显示文摘	Genovese MC McKay JD Nasonov EL	2008	Arthritis Rheum2008，58，10：	1
11	Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease显示文摘	Barskova VG Eliseev MS Nasonov EL	2004	Ter Arkh2004，76，5：	1
12	The role of regulatory T-cells in autoimmune rheumatic diseases显示文摘	Nasonov EL Bykovskaia SN	2006	Vestn RossAkad Med Nauk2006，，910：	1
13	Serum neopterin in hepatitis B显示文摘	Samsonov M Golban TD Nasonov EL	1992	Klin Med (Mosk)1992，70，：	1
14	Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease 显示文摘	Barskova VG Eliseev MS Nasonov EL	2004	Ter Arkh2004，76，5：	1
15	The role of bi- omarkers in diagnostics and forecasting of effectiveness of modern therapy of rheumatoid arthritis显示文摘	Aleksandrova EN Novikov AA Nasonov EL	2013	Klin Lab Diagn2013，，8：	1
16	Interleukin-6receptor inhibition with tocilizumab reduces disease activity inrheumatoid arthritis with inadequate response to disease-modifyingantirheumatic drugs: the tocilizumab in combination withtraditional disease-modifying antirheumatic drug therapy study 显示文摘	Genovese MC McKay JD Nasonov EL	2008	Arthritis Rheum2008，58，10：	1
17	Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases 显示文摘	Aleshkin VA Nasonov EL Eremeeva MV	1989	Ter Arkh1989，61，6：	1
18	Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis显示文摘	Bestaev DV Karateev DE Nasonov EL	2013	Ter Arkhiv2013，85，5：	1
19	Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs:the tocilizumab in combination with traditional disease-modifying antirheumatic drug ther显示文摘	Genovese MC McKay JD Nasonov EL		0，，：	1
20	Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs:the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study显示文摘	Genovese MC McKay JD Nasonov EL	2008	Arthritis Rheum2008，58，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示